LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media
6 Articles
6 Articles
LiveSpo® NAVAX Launches Probiotic Nasal Spray to Support ENT Treatment
HANOI, VIETNAM - Media OutReach Newswire - 19 May 2025 - LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking international scientific journal Scientific Reports-Nature, recognizing its effectiveness in supporting the treatment of rhinosinusitis and otitis media in children. This marks the third consecutive study on the product published in a prestigious internation…
LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the
HANOI, VIETNAM – Media OutReach Newswire – 19 May 2025 – LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking international scientific journal Scientific Reports-Nature, recognizing its effectiveness in supporting the treatment of rhinosinusitis and otitis media in children. This marks the third consecutive study […]

LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media
HANOI, VIETNAM – Media OutReach Newswire – 19 May 2025 – LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking international scientific journal Scientific Reports-Nature, recognizing its effectiveness in supporting the treatment of rhinosinusitis and otitis media in children. This marks the third consecutive study […]
LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media - Brand Spur
HANOI, VIETNAM – Media OutReach Newswire – 19 May 2025 – LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking international scientific journal Scientific Reports-Nature, recognizing its effectiveness in supporting the treatment of rhinosinusitis and otitis media in children. This marks the third consecutive study on the product published in a prestigious internation…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage